Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

Study ID: NCT06507748
Start Date: 2026-02-03
End Date: 2026-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

AlgometRx Nociometer

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder

Study ID: NCT06934915
Start Date: 2026-11
End Date: 2029-02
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

32

Intervention / Treatment

Prednisone

Placebo

Sponsor

Christopher John McDougle, M.D.

Source: clinicaltrials.gov

Share:
Add to list

Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)

Study ID: NCT06868914
Start Date: 2026-02-03
End Date: 2028-01-13
Study Type

Interventional

Study Phase

Phase1

No. of Participants

35

Intervention / Treatment

TMS (MagVenture MagPro 100 with MagOption)

Sponsor

National Institute on Drug Abuse (NIDA)

Source: clinicaltrials.gov

Share:
Add to list

High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department

Study ID: NCT07278648
Start Date: 2026-02-05
End Date: 2026-03-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Antithrombotic therapy

Sponsor

Health Consortium of Alt Penedès and Garraf

Source: clinicaltrials.gov

Share:
Add to list

Reliability of Transcutaneous Bilirubin Measurement According to the Skin Colour of Newborns

Study ID: NCT07315126
Start Date: 2026-03
End Date: 2027-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

510

Intervention / Treatment

Skin color assessment

Sponsor

Public Assistance - Paris Hospitals

Source: clinicaltrials.gov

Share:
Add to list

A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia

Study ID: NCT07283640
Start Date: 2026-05-18
End Date: 2031-08-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Revumenib

Blinatumomab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Young Adult Couples

Study ID: NCT06422299
Start Date: 2026-07-15
End Date: 2027-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Online, couples-based intervention

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Study of 18FET PET in Functional Pituitary Adenomas With Indeterminate MRI Findings

Study ID: NCT07360548
Start Date: 2026-03
End Date: 2030-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

fluoroethyl-L tyrosine (18F)

Sponsor

University Hospital, Lille

Source: clinicaltrials.gov

Share:
Add to list

Bladder Overactivity and Post-Botulinum Toxin Telemonitoring

Study ID: NCT07379372
Start Date: 2026-03-02
End Date: 2031-03-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

112

Intervention / Treatment

home care

Sponsor

University Hospital, Grenoble

Source: clinicaltrials.gov

Share:
Add to list

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

Study ID: NCT07339111
Start Date: 2026-02-15
End Date: 2029-06-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1200

Intervention / Treatment

CARTISTEM® + Debridement

Debridement

Sponsor

Medipost, Inc.

Source: clinicaltrials.gov

Share:
Add to list